The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
| dc.contributor.author | Amin Mostafa, Arwa Mohamed | |
| dc.date.accessioned | 2017-08-24T06:40:44Z | |
| dc.date.available | 2017-08-24T06:40:44Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Clopidogrel is a substantial antiplatelet drug. Some patients on clopidogrel treatment suffer from high on treatment suffer from high on treatment platelets reactivity (HTPR) which may lead to poor outcome. | en_US |
| dc.identifier.uri | http://hdl.handle.net/123456789/4419 | |
| dc.title | The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing | en_US |
| dc.type | Thesis | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: